|
Synonyms: compound 47 [PMID: 42370792] | PIPE791
Compound class:
Synthetic organic
Comment: PIPE-791 is a brain-penetrant lysophosphatidic acid receptor 1 (LPA1R; LPAR1) antagonist [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| No information available. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT6810245 | Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain | Phase 1 Interventional | Contineum Therapeutics | ||
| NCT05983939 | Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers | Phase 1 Interventional | Contineum Therapeutics | ||
| NCT07284459 | Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis | Phase 2 Interventional | Contineum Therapeutics | ||